Get the Stockscreener App
1.35
17.39%
0.20
Pre-market:
1.40
0.05
+3.70%
Myomo Inc stock is traded at $1.35, with a volume of 1.33M.
It is up +17.39% in the last 24 hours and up +48.34% over the past month.
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
See More
Previous Close:
$1.15
Open:
$1.2
24h Volume:
1.33M
Relative Volume:
2.38
Market Cap:
$52.16M
Revenue:
$40.93M
Net Income/Loss:
$-15.57M
P/E Ratio:
-3.6261
EPS:
-0.3723
Net Cash Flow:
$-17.84M
1W Performance:
+5.47%
1M Performance:
+48.34%
6M Performance:
+35.00%
1Y Performance:
-51.79%
1-Day Range:
$1.19
$1.415
1-Week Range:
$1.14
$1.59
52-Week Range:
$0.605
$2.89
Myomo Inc Stock (MYO) Company Profile
Name
Myomo Inc
Sector
Industry
Phone
617-996-9058
Address
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
1.35 | 52.16M | 40.93M | -15.57M | -17.84M | -0.3723 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Initiated | Craig Hallum | Buy |
| May-20-24 | Initiated | Lake Street | Buy |
| Dec-15-23 | Initiated | H.C. Wainwright | Buy |
| Nov-11-20 | Upgrade | ROTH Capital | Neutral → Buy |
| May-27-20 | Initiated | Dougherty & Company | Buy |
| Oct-02-17 | Initiated | H.C. Wainwright | Buy |
View All
Myomo Inc Stock (MYO) Latest News
MYOMO INC (MYO) Stock Chart - ChartMill
Myomo (NYSE: MYO) CMO sells shares to cover income tax bill - Stock Titan
Myomo (MYO) CCO uses 9,061 shares to cover RSU tax obligations - Stock Titan
Myomo (MYO) CFO has 10,969 shares withheld to cover RSU tax bill - Stock Titan
Myomo (MYO) RSUs Vest 20,979; Director reported sales on multiple dates - Stock Titan
Myomo (MYO) RSUs vest 19,813 shares; insider sales reported - Stock Titan
Myomo director Thomas F Kirk buys $50,802 in common stock By Investing.com - Investing.com Australia
Myomo director Thomas F Kirk buys $50,802 in common stock - Investing.com
Insider Buying: Thomas Kirk Acquires 40,002 Shares of Myomo Inc (MYO) - GuruFocus
MYOMO (MYO) CCO uses 6,529 shares to cover RSU tax liability - Stock Titan
MYOMO (MYO) Chief Medical Officer disposes shares to cover RSU tax - Stock Titan
Myomo (NYSE: MYO) CFO uses 10,050 vested shares to cover tax bill - Stock Titan
Director F. Kirk Thomas adds 40,002 Myomo (NYSE: MYO) shares in open-market buy - Stock Titan
MYO Maintained by Ascendiant Capital -- Price Target Raised to $10.00 - GuruFocus
Myomo CCO Mitchell Micah sells $77,688 in stock By Investing.com - Investing.com Australia
Myomo CCO Mitchell Micah sells $77,688 in stock - Investing.com
Myomo (NYSE American: MYO) lists 17,666 RSUs vesting; brokered sales reported - Stock Titan
Myomo (MYO) Chief Commercial Officer sells 90,231 shares in May 2026 - Stock Titan
Myomo (MYO) Form 144: Insider notice for 16,666 RSU shares vesting - Stock Titan
Number of shareholders of Myomo Inc. – AMEX:MYO - TradingView
Myomo director Thomas Kirk buys $24,825 in company stock By Investing.com - Investing.com South Africa
Myomo director Thomas Kirk buys $24,825 in company stock - Investing.com India
Myomo (MYO) director buys 25K open-market shares of Common Stock - Stock Titan
Myomo (MYO) shows fast-paced momentum but is still a bargain stock - MSN
Myomo CMO Kovelman sells $32,239 in company stock By Investing.com - Investing.com UK
Insider Sell Alert: Harry Kovelman Sells 32,000 Shares of Myomo Inc (MYO) - GuruFocus
Myomo CMO Kovelman sells $32,239 in company stock - Investing.com
MYOMO (MYO) Chief Medical Officer sells 32,000 shares in open-market trades - Stock Titan
Rule 144 Notice: MYO (NYSE) — 11,536 Common Shares Listed for Sale - Stock Titan
Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance
MYO (NYSE) affiliate lists multiple restricted stock sales on Form 144 - Stock Titan
Myomo, Inc. (MYO) reports Q1 loss, beats revenue estimates - MSN
MYO: Wearable robotics drive growth with expanding reimbursement and recurring revenue focus - TradingView
MYO: Recurring revenue and expanded payer coverage fuel growth and improved financial outlook - TradingView
MYO: Recurring revenue and expanded coverage drive growth, with 2026 revenue guided at $43–$46 million - TradingView
Myomo reiterates $40M–$42M 2025 revenue target as O&P channel, MyoConnect drive growth - MSN
Myomo director Kirk Thomas F buys $68,242 in company stock By Investing.com - Investing.com Nigeria
Myomo (MYO) director adds 75,006 shares through open‑market buying - Stock Titan
Myomo director Kirk Thomas F buys $68,242 in company stock - Investing.com
Myomo | 4: Statement of changes in beneficial ownership of securities-Director KIRK THOMAS F - Moomoo
Myomo director Manko Jr. acquires $173,907 in MYO stock By Investing.com - Investing.com South Africa
Horton Capital (MYO) reports 6% Myomo stake, wins board role and pushes declassification - Stock Titan
Myomo director Manko Jr. acquires $173,907 in MYO stock - Investing.com
Director-linked Horton Capital fund boosts Myomo (NYSE: MYO) stake with open-market buys - Stock Titan
Myomo Inc Stock (MYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):